Tuberculosis Competitive Landscape Intensifies as Biofabri, GSK, Otsuka, and Emerging Biotechs Drive Innovation | DelveInsight
DelveInsight's Tuberculosis Market Forecast 2032
DelveInsight's Tuberculosis Market Forecast 2032 projects significant growth across the 7MM, driven by leading companies such as Biofabri, GlaxoSmithKline, Otsuka Pharmaceutical, Sequella Inc., Global Alliance for TB Drug Development, and Spero Therapeutics. These players are advancing innovative therapies - such as MTBVAC, GSK3036656, and RUTI -...
0 Comments
0 Shares
French
Dutch